1. Academic Validation
  2. L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro

L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro

  • Virology. 2004 Sep 1;326(2):203-19. doi: 10.1016/j.virol.2004.06.005.
Ryan A Reinke 1 Deborah J Lee Brenda R McDougall Peter J King Joseph Victoria Yingqun Mao Xiangyang Lei Manfred G Reinecke W Edward Robinson Jr
Affiliations

Affiliation

  • 1 Department of Microbiology and Molecular Genetics, University of California, Irvine 92697-4800, USA.
Abstract

The human immunodeficiency virus (HIV) integrase (IN) must covalently join the viral cDNA into a host chromosome for productive HIV Infection. l-Chicoric acid (l-CA) enters cells poorly but is a potent inhibitor of IN in vitro. Using quantitative real-time polymerase chain reaction (PCR), l-CA inhibits integration at concentrations from 500 nM to 10 microM but also inhibits entry at concentrations above 1 microM. Using recombinant HIV IN, steady-state kinetic analyses with l-CA were consistent with a noncompetitive or irreversible mechanism of inhibition. IN, in the presence or absence of l-CA, was successively washed. Inhibition of IN diminished, demonstrating that l-CA was reversibly bound to the protein. These data demonstrate that l-CA is a noncompetitive but reversible inhibitor of IN in vitro and of HIV integration in vivo. Thus, l-CA likely interacts with Amino acids other than those which bind substrate.

Figures
Products